Skip to main navigation Skip to search Skip to main content

A Phase III Double-Blinded, Placebo Controlled Study of Xilonix for Improving Survival in Metastatic Colorectal Cancer

  • Keresztes, Roger (CoPI)
  • Choi, Minsig (PI)
  • Kudelka, Andrzej (CoPI)
  • Zhang, Yue (CoPI)

Project: Research

Project Details

StatusFinished
Effective start/end date06/23/1503/8/18

Funding

  • XBiotech USA Incorporated: $80,724.80